Skin Basal Cell Carcinoma

subtype

Identifier: CI-CAN-00003940
Entity page: /cancer/skin-basal-cell-carcinoma ↗
Edges: 304

Neighbours: 15 genes15 drugs10 trials
Drawn: 40 of 40 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Skin Basal Cell Carcinoma approved for …APPROVED_FORderived1 of 1
← approved for	Imiquimodsmall molecule EMA (EU) · approved · 1998-09-18 · Imiquimod cream is indicated for the topical treatment of : External genital and perianal warts (condylomata acuminata) in adults. Small su…	—	approved	Superficial Basal Cell Carcinoma	1	Regulatory	ema	graph →
Skin Basal Cell Carcinoma …

Skin Basal Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 20show all (up to 200)
→ investigated in trials for	Fluorouracilsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloridesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Imiquimodsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Arsenic Trioxidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Methyl Aminolevulinatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sonidegibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cemiplimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Everolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Filgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Gefitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →

Skin Basal Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 20show all (up to 200)

→ investigated in trials for

Fluorouracilsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Skin Basal Cell Carcinoma studied in …STUDIED_INderived10 of 83show all (up to 200)
→ studied in	NCT07144384early Phase 1 · completed Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07831083completed Skin Cancer Among Outdoor Workers · condition mapped ALIAS · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06398418Phase 1 · recruiting R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors · condition mapped ALIAS · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07803406recruiting Multimodal Imaging of Basal Cell Carcinoma: A Usability Study · condition mapped ALIAS · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05935995NA · completed Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination · condition mapped ALIAS · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07786376not yet recruiting AI in Histipathological Diagnosis of Bcc · condition mapped ALIAS · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07682831NA · recruiting Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies · condition mapped ALIAS · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07773688NA · recruiting Two-photon Fluorescence Microscopy of Dermatologic Biopsies · condition mapped ALIAS · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05859074Phase 1 · recruiting A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer · condition mapped ALIAS · 83 trials mapped (25 active)	—	—	Skin Basal Cell Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains